Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, after Year Five
Caterpillar Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, after Year Five decreased by 10.5% to $17.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, after Year Five shows a downward trend with a -7.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
A large value indicates significant long-term support, reducing the future cash burden of retiree benefits.
Detailed definition
This represents the aggregate expected cash inflows from government subsidies related to prescription drug benefits prov...
Peer comparison
Standard disclosure for companies with significant legacy retiree healthcare liabilities.
other_prescription_drug_subsidy_receipts_after_year_fiveHistorical Data
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $20.00M | $19.00M | $17.00M |
| QoQ Change | — | -5.0% | -10.5% |
| YoY Change | — | -5.0% | -10.5% |
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, after Year Five at Other Companies
Frequently Asked Questions
- What is Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, after year five?
- Caterpillar (CAT) reported defined benefit plan, expected future prescription drug subsidy receipt, after year five of $17.00M in Q4 2025.
- What is the long-term trend for Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, after year five?
- Over 2 years (2023 to 2025), Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, after year five has grown at a -7.8% compound annual growth rate (CAGR), from $20.00M to $17.00M.
- What does defined benefit plan, expected future prescription drug subsidy receipt, after year five mean?
- Total expected government payments for retiree prescription drug costs after the fifth year.